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Abstract
Background: To evaluate vision-related and health-related quality of life (VRQoL, HRQoL) in first stroke patients
with homonymous visual field defects (VFD) with respect to the extent of the lesion. Since VFD occur in
approximately 10% of stroke patients the main purpose of the study was to investigate the additional impact of
VFD in stroke patients hypothesizing that VFD causes diminished VRQoL.
Methods: In 177 first stroke patients with persisting VFD 2.5 years after posterior-parietal lesions VRQoL was
assessed by the National-Eye-Institute-Visual-Functioning-Questionnaire (NEI-VFQ) and HRQoL by the Medical-
Outcome-Study Short-Form-36 Health-Survey (SF-36). Questionnaire results of VFD-patients were compared with
age- and sex-matched healthy controls and with general non-selected stroke samples as published elsewhere. VFD-
type and visual acuity were partially correlated with questionnaire results.
Results: Compared to healthy controls VFD-patients had lower NEI-VFQ scores except ocular pain (Z-range -11.34
to -3.35) and lower SF-36 scores except emotional role limitations (Z-range -7.21 to -3.34). VFD-patients were less
impaired in SF-36 scores than general stroke patients one month post lesion (6/8 subscales) but had lower SF-36
scores compared to stroke patients six months post lesion (5/8 subscales). Visual acuity significantly correlated with
NEI-VFQ scores (r-range 0.27 to 0.48) and VFD-type with SF-36 mental subscales (r-range -0.26 to -0.36).
Conclusions: VFD-patients showed substantial reductions of VRQoL and HRQoL compared to healthy normals, but
better HRQoL compared to stroke patients one month post lesion. VFD-patients (although their lesion age was four
times higher) had significantly lower HRQoL than a general stroke population at six months post-stroke. This
indicates that the stroke-related subjective level of HRQoL impairment is significantly exacerbated by VFD. While
VRQoL was primarily influenced by visual acuity, mental components of HRQoL were influenced by VFD-type with
larger VFD being associated with more distress.
Background
Homonymous visual field defects (VFD) are among the
most common disorders after posterior-parietal strokes
and can severely reduce vision-related quality of life
(VRQoL) [1-3]. It is known that diminished VRQoL is
correlated with the extent of visual field loss after cere-
bral injury [1-3]. A correlation between visual field loss
and quality of life was also shown in a large population-
based cross-sectional study [4] and for different ophthal-
mologic diseases resulting in VFD such as glaucoma
[5-11], retinal lesions [12,13] or optic neuropathy [14]
(An overview of these studies which investigated the
association of visual field impairment and quality of life
is given in an additional file 1).
The impact of VFD on health-related quality of life
(HRQoL) in general and VRQoL in particular, assessed
in first stroke patients with VFD, has not yet been inves-
tigated in sufficient detail. Two studies with small sam-
ple sizes showed that diminished vision-related QoL is
moderately correlated with the extent of visual field loss
after cerebral injury to the postchiasmatic pathway.
While one study focused on the area of sparing within
the affected half of the visual field [1], the second study
took the total area of visual field loss as the relevant
parameter [2]. However, the etiology of these studies
was not restricted on first stroke. In a recent study on
VRQoL and HRQoL, we investigated a large sample of
312 brain-injured patients with postchiasmatic VFD and
* Correspondence: carolin.gall@med.ovgu.de
1Otto-von-Guericke University of Magdeburg, Medical Faculty, Institute of
Medical Psychology, Leipziger Str. 44, 39120 Magdeburg, Germany
Gall et al. Health and Quality of Life Outcomes 2010, 8:33
http://www.hqlo.com/content/8/1/33
© 2010 Gall et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.observed a coordinate influence of VFD and visual
acuity on VRQoL in particular, but also on HRQoL [3].
The etiology of this sample was quite heterogenous and
did not allow us to conclude on quality of life in first
stroke patients with VFD.
There are several studies focussing on HRQoL among
stroke patients during the course of rehabilitation or on
long-term follow-up [15-18]. HRQoL assessments are an
essential evaluation tool in healthcare and medical treat-
ments [19], but usually measures such as neurological
scores and disability scales are used. These are of only
limited value to capture changes of the patient’s subjec-
tive health status and insensitive to assess if patients
have fully regained independence in everyday life [20].
The latter is the case in two thirds of the stroke patients
who are alive 6 months after the lesion [21]. The most
frequently used disability scales are the Barthel ADL
Index [22] and the Functional Independence Measure
[23] both commonly used to show improvements in
functional status during inpatient stroke rehabilitation.
However, because of ceiling effects these kinds of mea-
sures do not capture deficits in more advanced activities
in the visual domain such as ‘going down steps, stairs,
or curbs in dim light or at night’, ‘seeing how people
react to things you say’ or ‘driving at night’.T h e s e
examples are items included in the National-Eye-Insti-
tute-Visual-Functioning-Questionnaire (NEI-VFQ)
which is an appropriate measure for VRQoL. Stroke
patients with VFD after older lesions but persistent
vision problems often adapt to or compensate for their
deficit and achieve functional independence, resulting in
relatively normal Barthel scores. Nevertheless, these
patients still have deficits in more advanced visual activ-
ities resulting in considerably diminished VRQoL [3].
O n ea i mo ft h ep r e s e n ts t u d yw a st oa s s e s sV R Q o L
and HRQoL in first stroke VFD-patients and to compare
the results with those of age- and sex-matched healthy
controls. Differences in self-rated VRQoL of more than
10 points are considered as clinically relevant [24,25].
The main purpose of the study was to investigate the
additional impact of visual field loss in stroke patients
on quality of life estimates hypothesizing that quality of
life - especially VRQoL - is lower in stroke patients with
than in stroke patients without VFD. Since HRQoL of
first stroke VFD-patients has not yet been contrasted
with general stroke patients with non-selected etiologies
the primary aim of the present study was to capture this
comparison. Both VRQoL and HRQoL estimates of
VFD-stroke patients were further correlated with demo-
graphic and lesion variables, VFD-type and visual acuity.
In addition, the influence of VFD size and visual acuity




All analyses were based on data concurrently collected
in two independent outpatient facilities for neurovisual
rehabilitation (Institute of Medical Psychology and
NovaVision center of excellence for visual therapy) in
Magdeburg, Germany, between 1998 and 2007 [3].
Patients who met the following criteria were included in
the study: (1) first posterior-parietal stroke; (2) clinical
evidence of VFD in computer based perimetry; (3) will-
ingness to participate in visual field diagnostics and
questionnaire assessment, able to make the required
study visits, and sufficient ability to follow instructions;
(4) age 18 or older, with no upper age limit; (5) lesion
older than 6 months; (6) absence of recurrent stroke
according to medical records.
Exclusion criteria were severe psychotic diseases, ser-
ious drug abuse, chronic degenerative diseases (demen-
tia, multiple sclerosis), severe motor impairments
(paresis in both arms), noticeably low intelligence, con-
siderably impaired visual acuity (corrected decimal bino-
cular acuity < 0.4 respectively > 0.4 LogMAR acuity) or
inability to fixate. First stroke patients with VFD asso-
ciated with hemispatial neglect were excluded from the
analyses (35) as well as patients with brain injuries with
etiologies different from first stroke, i.e. recurrent stroke
(25), non-progressive or extirpated brain tumors (38),
traumatic brain injury (30), encephalitis (4), ectomy for
epilepsy (2), and anoxic brain (1).
All patients were treated according to the ethical stan-
dards of the Declaration of Helsinki (1964). Ethical
approval was not obtained according to local regulations
because the present study required only answering ques-
tions without risk of psychological distress. For self
assessment NEI-VFQ-39 and SF-36 questionnaires were
sent to the patients by mail [26]. All patients were
informed that answering the questionnaires was volun-
tary. Patients were asked to answer the questionnaires
without help. All included subjects were able to compre-
hend the questions contained in the NEI-VFQ and
SF-36.
Out of a total sample of 312 patients with cerebral
injury resulting in postchiasmatic VFD 177 first stroke
patients were selected for data analyses. Lesions were
either ischemic (139) or hemorrhagic (38). Mean age
was 57.4 years (SD = 13.76, range 21-83). 114 patients
(64.4%) were male, 63 (35.6%) female. Mean lesion age
was 30.69 (months) (SD = 40.30, range 6-277), i.e. on
average more than 2.5 years. The type of VFD was com-
plete hemianopia (n = 34), incomplete hemianopia (n =
72), quadrantanopia (n = 31), tunnel vision (n = 5), sco-
toma (n = 3), diffuse loss of vision (n = 23) and VFD
affecting three quadrants (n = 9).
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VFQ (VRQoL) and SF-36 (HRQoL), demographic data,
stroke-type (i.e. ischemic or hemorrhagic), visual field
examinations, topography of the visual field loss (i.e.
VFD-type), and visual acuity.
Vision-related quality of life
The NEI-VFQ was originally designed to measure
VRQoL in patients with chronic eye diseases [27]. In the
present study the validated German 39-item version of
the NEI-VFQ was used in self-administered format [28].
The questionnaire consists of 39 rating items with 12
subscales: (1) general health (2 items); (2) general vision
(2 items); (3) ocular pain (2 items); (4) difficulties with
near vision activities (6 items); (5) difficulties with dis-
tance vision activities (6 items); (6) limitations in social
functioning due to vision (3 items); (7) mental health
symptoms due to vision problems (5 items); (8) role dif-
ficulties due to vision problems (4 items); (9) depen-
dency on others due to vision problems (4 items); (10)
driving problems (3 items); (11) color vision problems
(1 item) and (12) peripheral vision problems (1 item). A
composite score was generated by averaging the 11
vision-related subscales without general health. Subscale
and composite scores ranged from 0 (“worst possible
functioning”)t o1 0 0( “best possible functioning”). NEI-
VFQ reference values of a German sample of healthy
control subjects were used for comparison [29].
Health-related quality of life
The Medical Outcome Study Short-Form 36 Health
Survey (SF-36) is a standard instrument for the assess-
ment of general HRQoL. This questionnaire was used to
quantify HRQoL in patients, independent of their actual
state of health or their age. The questionnaire consists
of 36 items subdivided into eight dimensions of subjec-
tive health: physical functioning (10 items), role limita-
tions due to physical problems (4 items), bodily pain (2
items), general health perceptions (5 items), vitality (4
items), social functioning (2 items), role limitations due
to emotional problems (3 items), and emotional well-
being (5 items). All items can be combined to form two
summary scales: the physical composite score and the
mental composite score. Composite scores were gener-
ated by adding the item responses and including given
loadings for the different dimensions. Subscale and com-
posite scores ranged from 0 ("worst possible function-
ing”) to 100 ("best possible functioning”). In the present
study the German translation of the SF-36 was self-
administered and patients were asked to rate the items
based on the experiences during the last four weeks
[30]. For comparison, SF-36 reference data of a German
sample of healthy control subjects were derived from
Bullinger & Kirchberger [30]. The reference sample also
answered the SF-36 considering the time frame of the
last four weeks.
Visual field diagnostics
The VFD-type was assessed as tunnel vision, VFD
affecting three quadrants, complete hemianopia, incom-
plete hemianopia, quadrantanopia, scotoma or diffuse
loss of vision. The diagnosis of the defect type was
based on campimetric (16° vertically × 21.5° horizon-
tally, “High Resolution Perimetry, HRP”) and perimetric
90° visual field measurements [31]. During a campi-
metric test 474 light stimuli were presented in a dense
grid of 19 × 25 stimulus locations. At least 70 times
during a campimetric visual field test, fixation accuracy
was tested by an isoluminant change of the fixation
point.
The campimetric visual field test was repeated three
times. The mean number of correctly detected stimuli
in campimetry in % served as an estimate for intact cen-
tral visual field and was 57.83% (SD = 16.56). Reliability
of the campimetric visual field examination was suffi-
cient: the percentage of false positive responses was
2.32% (SD = 4.79), mean fixation accuracy was 93.09%
(SD = 11.82%).
The eccentricity of the VFD was analyzed in a sub-
sample of 90 patients with available digital visual field
data. This subsample did not differ from the remaining
87 patients with respect to the mean number of cor-
rectly detected stimuli and reliability parameters. At
each of the 474 tested positions three stimuli were pre-
sented, i.e. one during each test. Since campimetry was
performed three times, a patient could detect between 0
and 3 out of 3 presented stimuli resulting in detection
rates between 0 and 1. The detection rate at each tested
position was multiplied by the eccentricity of the respec-
tive position. These 474 detection rates weighted by
eccentricity were added and divided by 474 resulting in
an individual value representing the mean eccentricity
of intact visual field.
Visual acuity
Best corrected visual acuity and reading speed were
measured at a 0.4 m distance with Landolt, Snellen or
the German-language Radner Reading Charts [32].
Visual acuity scores were analyzed through the calcula-
tion of weighted average LogMAR (WMAR) [33,34].
The numerator of the visual acuity score was divided by
the denominator, and the base 10 logarithm of the result
was calculated. WMAR then summarized the acuity data
from both eyes in one score giving a 0.75 weighting to
the better eye and a 0.25 weighting to the worse eye.
Visual acuity scores were finally percentage transformed.
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NEI-VFQ and SF-36 scores of the first stroke sample
were compared to reference values of age- and sex-
matched healthy controls with the Wilcoxon test. The
NEI-VFQ reference group (mean age = 49.88; SD =
16.8; range 21-79) consisted of 353 healthy controls
(54.7% female) that was recently analyzed as a control
group for stroke patients with homonymous visual field
loss [29]. There were no differences concerning age and
s e xb e t w e e nt h ep r e s e n tf i r s ts t r o k es a m p l ea n dt h e
healthy controls.
SF-36 reference data was derived from values pub-
lished in the German SF-36 manual [30] of a control
group consisting of 2914 healthy controls (age range 14
to >70 years, only persons older than 21 years were cho-
sen for the present study).
The total sample of first stroke patients with VFD was
subdivided into six age categories separately for males
and females (21-30, 31-40, 41-50, 51-60, 61-70, >70
years). Mean NEI-VFQ and SF-36 scores of the corre-
sponding sex and age-category were assigned to each
VFD-patient. Thus, the group comparison was per-
formed with averaged reference values specific to the
first stroke sample. There were no differences concern-
ing age and sex between the present first stroke sample
and the healthy controls.
Standard-Deviation-Scores (SDS) were calculated as
average NEI-VFQ respectively SF-36 subscale scores in
the first stroke sample minus corresponding average
values of healthy controls divided by the standard devia-
tion of healthy controls [29,30]. SDS-scores were also
evaluated for patients with different lesion ages (1 and 6
months), previously published by Rønning and Stavem
[17]. 179 stroke patients aged ≥ 60 years with intracer-
ebral haemorrhage and prior stroke(s) were included in
this study [17]. Since Rønning and Stavem did not
report values for SF-36 physical and mental composite
scores, reference values reported by Suenkeler et al. [35]
for both composite scores were used for evaluating
SDS-scores. The authors studied HRQoL in 144
ischemic or hemorrhagic stroke/TIA patients (mean age
65.3 years) at 3, 6 and 12 months post stroke [35].
Partial parametric correlation coefficients were calcu-
lated between NEI-VFQ and SF-36 composite and sub-
scale scores and age, lesion age, visual acuity and
computer campimetry results. For nonparametric vari-
ables (sex, etiology, type of VFD) partial gamma correla-
tions were calculated.
For further analyses the sample was divided into four
groups according to their residual intact central visual
field, measured as the number of correctly detected stimuli
in campimetry (in %): 0-25%, 26-50%, 51-75% and 76-
100%. Group differences were also studied for the factor
visual acuity. Therefore, patients were assigned to one of
the two groups: 0-50% and >50% visual acuity (0% corre-
sponds to 0.4 decimal acuity respectively 0.4 LogMAR
acuity). Mean NEI-VFQ and SF-36 composite and sub-
scale scores were compared between groups with different
intact visual field size and with different levels of visual
acuity using analyses of variance with post-hoc t-tests in
case of significant main effects. The level of significance
was adjusted by the number of subscale comparisons
(NEI-VFQ: 0.05/12 = 0.00417; SF-36: 0.05/8 = 0.00625).
Results were displayed as mean ± standard deviation
(M ± SD) concerning averaged questionnaire results and
as mean ± standard error (M ± SE) in case of SDS-scores.
Statistical analyses were carried out with SPSS 15.0.
Results
Comparison of quality of life estimates between healthy
controls and patients with VFD
Compared with healthy age- and sex-matched control
subjects first stroke VFD-patients had significantly lower
VRQoL in the NEI-VFQ composite score and in 11 of
12 NEI-VFQ subscales, Wilcoxon Z-range -3.35 to-
11.34; all P < 0.001, (Table 1). Only the subscale ocular
pain did not differ to healthy controls (Z = -1.34; n.s).
Between group differences exceeded more than 10
points for 10/12 subscales; the subjective impairment
was therefore considered as clinically relevant [24,25].
Comparison of first stroke VFD-patients with healthy
SF-36 control values from Bullinger & Kirchberger [30]
revealed lower HRQoL scores in VFD-patients in 7 of 8
SF-36 scales, Wilcoxon Z-range: -3.34 to-7.21; all P <
0.001, (Table 1). The difference between the samples for
role limitations due to emotional problems did not
reach significance. VFD-patients had higher scores than
controls in the subscale bodily pain (Z = 3.41; P < 0.01).
Figure 1 demonstrates the relation between dimin-
ished VRQoL of first stroke VFD-patients relative to
healthy controls with the aid of SDS-scores. Except for
the subscale ocular pain, NEI-VFQ results of first stroke
VFD-patients were always below average scores of age-
and sex-matched controls (Figure 1). The mean NEI-
VFQ SDS-score was -3.36 (SD = 2.13). Role difficulties,
driving and peripheral vision showed the largest devia-
tions with SDS-scores below -5.
Relating SF-36 values of VFD-patients to healthy con-
trols SDS-scores for all scales except for bodily pain
were below the average of healthy controls. Only the
SDS of role limitations due to emotional problems
deviated by more than -5 (Figure 2). Mean SF-36 SDS-
score was -2.66 (SD = 5.07).
Comparison of quality of life estimates between general
stroke samples and patients with VFD
Figure 3 shows SDS-scores comparing the sample of
first stroke patients with VFD with stroke patients in
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Page 4 of 14Table 1 NEI-VFQ and SF-36 results of first stroke patients with VFD compared with healthy age- and sex-matched
controls





MS DM S D
NEI-VFQ (N)
NEI-VFQ composite score (177) 63.98 16.89 92.06 4.73 -28.08 -10.54 ‡
1. General health (173) 49.14 19.9 63.93 11.89 -14.79 -7.04 ‡
2. General vision (173) 57.23 17.88 78.72 8.39 -21.49 -10.48 ‡
3. Ocular pain (175) 86.86 16.04 86.19 7.21 0.67 1.34 (n.s.)
4. Near vision (177) 65.25 22.69 89.17 9.38 -23.92 -10.17 ‡
5. Distance vision (177) 72.75 21.31 91.12 8.94 -18.37 -8.82 ‡
6. Social functioning (177) 74.65 23.33 93.62 7.77 -18.97 -8.83 ‡
7. Mental health (174) 59.43 24.19 86.17 11.65 -27.28 -9.64 ‡
8. Role difficulties (175) 51.87 22.59 90.01 5.26 -38.14 -11.34 ‡
9. Dependency (173) 67.21 30.47 93.78 7.51 -26.57 -8.61 ‡
10. Driving (153) 27.35 33.89 88.30 8.02 -60.95 -9.43 ‡
11. Color vision (172) 86.92 22.69 94.26 6.54 -7.34 -3.35 ‡
12. Peripheral vision (175) 49.29 24.19 92.06 8.21 -42.77 -11.03 ‡
SF-36 (N)
1. Physical functioning (173) 66.41 27.10 80.53 10.06 -14.12 -4.96 ‡
2. Role limitations (physical) (174) 47.99 43.30 78.82 8.79 -30.81 -7.21 ‡
3. Bodily pain (174) 81.06 24.76 74.79 6.42 6.27 3.41 ‡
4. General health perceptions (173) 56.37 21.13 62.61 6.02 -6.24 -3.34 ‡
5. Vitality (176) 53.25 19.88 62.03 3.65 -8.78 -5.14 ‡
6. Social functioning (176) 74.79 26.34 87.56 2.66 -12.77 -5.01 ‡
7. Role limitations (emotional) (170) 71.76 42.75 89.21 2.78 -17.45 -1.29 (n.s.)
8. Emotional well-being (176) 66.64 18.91 74.67 2.71 -8.03 -4.54 ‡
* P <0 . 0 5 ;† P < 0.01; ‡ P < 0.001;
1 NEI-VFQ reference values [29]. SF-36 reference values [30]. a-adjusted significance-level is 0.00417 for NEI-VFQ and 0.00625
for SF-36. Healthy controls were matched by sex and age.
Figure 1 SDS-scores for NEI-VFQ of first stroke VFD-patients compared with a healthy reference group. SDS was calculated as average
NEI-VFQ subscale scores in the first stroke VFD-sample minus the average value of healthy NEI-VFQ control subjects divided by the standard
deviation of the control sample. The zero-line represents the baseline value of the control group sample without stroke. All NEI-VFQ SDS-scores
(except ocular pain) are negative indicating that first stroke VFD-patients suffer from lower VRQoL than healthy controls.
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Page 5 of 14Figure 2 SDS-scores for SF-36 results of first stroke VFD-patients compared to a healthy reference group. Data of healthy reference
subjects [30]. Only the SDS-score for the subscale bodily pain was positive which indicates that first stroke VFD-patients suffer from lower HRQoL
than healthy controls.
Figure 3 SDS-scores for SF-36 subscales of first stroke VFD-patients compared to stroke patients with different lesion ages.D a t ao f
stroke patients with different lesion ages [17]. SDS was calculated as average SF-36 subscale score in the first stroke VFD-sample minus average
value of stroke patients one months post lesion (grey) or six months post lesion (black) divided by the standard deviation of the stroke groups
with different lesion ages.
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different lesion ages (1 month vs. 6 months) were ori-
ginally published by Rønning and Stavem [17]. VFD-
patients showed significantly better SF-36 scores than
stroke patients with a lesion age of 1 month (Z-range
-6.56 to -9.29; P < 0.001) except for the subscales gen-
eral health perceptions (Z = -1.37, n.s.; SDS-score
approx. 0) and emotional well-being (Z = -0.56, n.s.;
SDS-score approx. 0). The mean SDS-score across all
SF-36 subscales was 0.55 (SD = 0.74) indicating slightly
better HRQoL in the first stroke VFD-sample compared
to stroke patients 1 month post lesion.
The SF-36 scores of stroke patients 6 months post
lesion were comparable to those of stroke patients with
V F Do n l yf o rt h es u b s c a l ev i t a l i t y( Z=- 0 . 2 ,n . s . ;S D S -
score approx. 0). In our sample, 5 of 8 SF-36 subscales
(role limitations due to physical problems, general
health perceptions, social functioning, role limitations
due to emotional problems and emotional well-being)
were significantly lower than in stroke patients with 6
m o n t h sl e s i o na g e( Z - r a n g e- 1 . 3 4t o- 3 . 7 5 ,a l lP <0 . 0 5 ;
SDS<0). However, two subscales were still slightly better
(physical functioning and bodily pain, Z = 1.95 and 4.57,
P < 0.05; SDS>0). The mean SDS-score comparing both
samples was -0.20 (SD = 0.84) indicating on average
slightly worse HRQoL in VFD-patients compared to
stroke patients 6 months post lesion (Figure 3).
Results of SF-36 composite scores of VFD-stroke
patients were also compared to results of stroke patients
with different lesion ages (3, 6 and 12 months) (Figure 4).
This reference data was originally published by Suenkeler
et al. [35]. First-stroke patients with VFD showed better
results for the physical composite score than stroke
patients with different lesion ages (3 months: Z = -4.58,
P < 0.0001; 6 months: Z = -4.21, P < 0.0001; 12 months:
Z = -3.99, P < 0.0001). In contrast, SDS-scores indicated
worse results for the mental composite score in VFD-
patients compared to patients with different lesion ages
(3 months: Z = -3.88, P < 0.0001; 6 months: Z = -3.77,
P < 0.0001; 12 months: Z = -2.13, P < 0.05).
Correlation analysis for QoL estimates with demographic
and lesion characteristics
NEI-VFQ and SF-36 subscales were partially correlated
with demographic variables, visual acuity and VFD-type
(Table 2). No significant correlations with NEI-VFQ
results were observed with demographic variables age,
sex, lesion age and etiology. The VFD-type showed some
low correlations (P <0 . 1 )w i t h4o f1 2N E I - V F Qs u b -
scales. The NEI-VFQ composite score and each subscale
except ocular pain, driving and peripheral vision corre-
lated significantly with visual acuity (r-range 0.27-0.48).
The mean eccentricity of detected stimuli in campime-
try (i.e. of the intact visual field), which was analyzed in
Figure 4 SDS-scores for SF-36 composite scores of first stroke VFD-patients compared to stroke patients with different lesion ages.
Data of stroke patients with different lesion ages [35]. SDS was calculated as average SF-36 composite score in the first stroke VFD-sample
minus average value of stroke patients three, six or twelve months post lesion divided by the standard deviation of the stroke groups with
different lesion ages.
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data, correlated significantly only with the peripheral
vision NEI-VFQ scale (r = 0.26, p < 0.05, n = 90).
Emotional well-being was the only SF-36 scale which
significantly correlated with visual acuity (r = 0.31; P <
0.05). SF-36 subscale physical functioning as well as the
physical composite score and mental composite score
were significantly correlated to the variable sex (r-range
-0.27 to 0.37), but SF-36 subscales did not correlate
with age, lesion age and etiology. Significant negative
correlations were observed between the type of VFD
and all 4 SF-36 subscales which compose the mental
composite score. Therefore mental composite scores
were descriptively compared between patients with dif-
ferent VFD-types tunnel vision patients (who typically
suffer from the most extensive loss of visual field)
expectedly had the lowest score of 39.45 compared to
patients of all other VFD types (complete hemianopia
48.91; incomplete hemianopia 49.06; quadrantanopia
46.74; scotoma 46.12; diffuse loss of vision 43.59; visual
field loss affecting three quadrants 45.66).
Variance analyses of QoL estimates with the factor
visual field size
The factor intact central visual field influenced every
NEI-VFQ subscale except general health, ocular pain
and driving (F-Range 3.16-14.11; all p < 0.05). Signifi-
cant group effects below the adjusted significance level
(0.00417) were observed for five NEI-VFQ subscales
(Figure 5). A significant group difference was also
observed for the NEI-VFQ composite score: 0-25%
intact visual field size: 41.67 ± 19.43; 26-50%: 57.59 ±
19.58; 51-75%: 65.31 ± 15.42; 76-100%: 71.82 ± 12.45;
(F = 7.66; p < 0.0001). In case of significant post hoc
analyses, these revealed better NEI-VFQ results in
patients with larger intact central visual field. Patients
with more than 75% correctly detected stimuli in campi-
metry rated their VRQoL more than 30 points better
Table 2 Partial correlation coefficients between NEI-VFQ and SF-36 results of first stroke VFD patients with
demographic and lesion variables, type of VFD and visual acuity
R Age Sex Lesion age Etiology
1 Visual field defect
2 Visual acuity
NEI-VFQ (N)
NEI-VFQ composite score (177) 0.51 0.01 -0.18 0.01 0.003 0.09 0.37 †
1. General health (173) 0.27 -0.09 -0.03 -0.01 0.14 0.24 § 0.27*
2. General vision (173) 0.52 -0.21 -0.13 -0.02 0.18 0.11 0.36 †
3. Ocular pain (175) / / / / / / /
4. Near vision (177) 0.48 -0.01 -0.16 0.05 0.06 0.11 0.48 ‡
5. Distance vision (177) 0.35 0.05 -0.15 0.08 -0.05 0.12 0.35 †
6. Social functioning (177) 0.45 -0.004 -0.12 -0.003 -0.08 0.07 0.45 ‡
7. Mental health (174) 0.38 0.05 0.03 0.004 -0.02 -0.24 § 0.38 †
8. Role difficulties (175) 0.46 0.06 -0.2 0.1 0.03 0.15 0.29 *
9. Dependency (173) 0.37 -0.02 -0.19 0.04 -0.05 -0.24 § 0.37 †
10. Driving (153) / / / / / / /
11. Color vision (172) 0.39 -0.2 -0.07 0.06 0.03 -0.22 § 0.39 †
12. Peripheral vision (175) / / / / / / /
SF-36 (N)
SF-36 physical composite score (169) 0.36 -0.2 -0.27 * 0.1 0.19 -0.05 0.16
1. Physical functioning (173) 0.47 -0.17 -0.28 * 0.02 0.16 -0.08 0.22 §
2. Role limitations (physical) (174) 0.42 -0.1 -0.15 0.21 § 0.19 -0.14 0.1
3. Bodily pain (174) / / / / / / /
4. General health perceptions (173) / / / / / / /
SF-36 mental composite score (169) 0.48 -0.04 0.37 † 0.01 0.004 -0.36 † 0.18
5. Vitality (176) 0.29 -0.1 0.20 § 0.18 0.03 -0.29 * 0.19
6. Social functioning (176) 0.32 0.02 0.24 § 0.003 -0.17 -0.32 † 0.12
7. Role limitations (Emotional) (170) 0.33 -0.04 0.22 § -0.02 0.03 -0.33 † 0.15
8. Emotional well-being (176) 0.42 -0.04 0.16 -0.01 0.01 -0.26 * 0.31 *
* P <0 . 0 5 ;† P < 0.01; ‡ P < 0.001; §P < 0.1. NEI-VFQ and SF-36 scores were partially correlated with demographic and lesion variables, type of VFD and visual
acuity.
1 The etiology was either ischemic (139) or hemorrhagic (38).
2 The type of VFD was complete hemianopia (34), incomplete hemianopia (72), quadrantanopia (31), tunnel vision (5), scotoma (3), diffuse loss of vision (23) and
visual field defect affecting three quadrants (9).
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Page 8 of 14(range 30.15-57.14; all p < 0.00417) than patients with
an intact central visual field of 0-25% regarding the sub-
scales distance vision, social functioning, role difficulties,
color vision and peripheral vision as well as the compo-
site score. Patients with an intact central visual field of
51-75% rated their VRQoL more than 20 points better
than patients with an intact visual field of 0-25% in the
subscales distance vision, social functioning, color vision
and in the composite score (range 23.64-45.57; all p <
0.00417). Compared to patients with an intact visual
field of 0-25%, patients with 26-50% estimated their
VRQoL more than 40 points better for subscale color
vision (39.14; p < 0.00417).
Figure 6 shows SF-36 subscale scores corresponding to
the factor visual field size. The intact central visual field
affected only SF-36 subscale role limitations (physical)
(F = 3.15; p < 0.05), but not significant at the adjusted
significance level (0.00625). However, there were no sig-
nificant post-hoc differences for this subscale. Further
there were no significant group differences for SF-36
composite scores: physical composite score: 0-25% intact
visual field size: 44.98 ± 10.08; 26-50%: 39.11 ± 11.92;
51-75%: 44.43 ± 9.91; 76-100%: 43.56 ± 8.76; (F = 1.89;
p = 0.133) and mental composite score: 0-25% intact
visual field size: 44.18 ± 9.79; 26-50%: 47.63 ± 10.35; 51-
75%: 47.29 ± 11.94; 76-100%: 49.65 ± 12.22; (F = 0.376;
p = 0.770).
Variance analyses of QoL estimates with the factor
visual acuity
Figure 7 shows NEI-VFQ and SF-36 subscale scores cor-
responding to the factor visual acuity. Stroke patients
with VFD were assigned to one of two groups with
either 0-50% or > 50% visual acuity. There was a trend
for significant differences between both groups in all
NEI-VFQ subscales except general health, ocular pain,
driving, color vision and peripheral vision (F-range 3.99-
8.32; all p < 0.05, but above 0.00417). Visual acuity
influenced SF-36 subscales physical functioning, vitality,
social functioning and emotional well-being (F-range
4.19-11.33; all p < 0.05, but only emotional well being
below 0.00625) as well. In patients with better visual
acuity higher NEI-VFQ and SF-36 results for the men-
tioned scales were observed. NEI-VFQ composite
score significantly differed between both groups: 0-50%:
58.31 ± 19.64; >50%: 68.14 ± 12.62; (F = 5.67; p = 0.02),
Figure 5 Distribution of mean NEI-VFQ scores of first stroke VFD-patients according to the extent of intact central visual field.T h e
stroke sample was divided in four groups corresponding to the remaining intact central visual field size measured as the number of correctly
detected stimuli in campimetry. The figure shows the distribution of mean NEI-VFQ scores of these four groups as well as results of healthy
control persons [29]. A significant group difference was also observed for the NEI-VFQ composite score (see text).
Gall et al. Health and Quality of Life Outcomes 2010, 8:33
http://www.hqlo.com/content/8/1/33
Page 9 of 14while the descriptive group difference for the SF-36
composite scores was lower: physical composite score:
0-50%: 40.90 ± 11.41; >50%: 45.24 ± 9.49 (F = 2.77; ns)
and mental composite score: 0-50%: 45.36 ± 10.28;
>50%: 51.69 ± 11.63 (F = 5.58; p = 0.02).
Discussion
Comparison of quality of life estimates between healthy
controls and patients with VFD
The results of this study indicate a strong difference
between VFD-patients and healthy controls which docu-
ments the substantial impact of vision impairment espe-
cially on subjectively perceived VRQoL. First, the
observed SDS-scores were lower for VRQoL than for
HRQoL (Figure 1) and second, VFD-patients differed
from healthy controls in all dimensions of the NEI-VFQ
except ocular pain (Table 1).
VFD-patients also showed significantly worse out-
comes in all SF-36 dimensions than healthy controls
except for the subscale role limitations due to emotional
problems (Table 1 and Figure 2). Thus, general HRQoL
as assessed with the SF-36 is still diminished 2.5 years
after first posterior-parietal stroke that caused persisting
VFD. The presented results complement those of pre-
vious studies [1-3]. However, these studies did not
control for different etiologies of the VFD [2,3] or stu-
died only a small sample [1,2].
Comparison of quality of life estimates between general
stroke samples and patients with VFD
Due to the availability of published HRQoL-results of a
general stroke population [17] that naturally also
included versatile and non-VFD functional impair-
ments it was possible to compare stroke patients after
different lesion ages and to concurrently rank subjec-
tively perceived HRQoL of the investigated VFD-sam-
ple with this stroke sample which was investigated one
and again six months after the lesion. One month post
stroke patients experienced the lowest HRQoL, but
their SF-36 scores improved by six months. Visually
impaired stroke patients finally showed worse HRQoL
than stroke patients six months post lesion, but better
results than patients one month after stroke (Figure 3).
This finding stresses the additional impact of VFD
above stroke on diminished HRQoL. In future work a
comparison of VRQol and HRQol between a stroke
sample with VFD and one without should be
attempted.
SF-36 results of VFD-stroke patients were also com-
pared to results of stroke patients with different lesion
Figure 6 Distribution of mean SF-36 scores of first stroke VFD-patients according to the extent of intact central visual field. The stroke
sample was divided in four groups corresponding to the remaining intact central visual field size measured as the number of correctly detected
stimuli in campimetry. The figure shows the distribution of mean SF-36 scores of these four groups as well as results of healthy control persons
[30]. There were also no significant group differences for SF-36 composite scores (see text).
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Page 10 of 14ages (3, 6 and 12 months) of a second general stroke
sample [35] (Figure 4). This comparison revealed better
results of VFD-patients for the physical composite score
but worse results for the mental composite score than
for stroke patients in general at any point of investiga-
tion. This implies that first stroke patients with VFD
after posterior-parietal strokes suffer from relatively iso-
lated loss of vision that are less often accompanied by
further neurological deficits such as motor impairment.
In contrast, motor impairment is more often in a gen-
eral stroke sample as published by Suenkeler et al. [35]
resulting in worse physical composite scores than in the
investigated sample of VFD-patients.
While quality of life estimates (both health-related and
vision-related) were severely reduced in the investigated
first stroke sample, Jobke et al. reported that no change
in personality features could be observed in patients
with visual field loss in general [36].
Figure 7 NEI-VFQ and SF-36 score differences between visual acuity groups, when the first stroke sample was divided in two groups
with visual acuity of 0-50% or >50%. Visual acuity scores were percentage transformed. 0% corresponds to 0.4 decimal acuity respectively 0.4
LogMAR acuity.
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as possible confounders
A non-selected stroke population has a variety of post
stroke deficits that can contribute to diminished
HRQoL. It is well known that stroke patients recover
rather well in non-visual functional domains such as
speech and motor problems. Duncan et al. reported that
most of the spontaneous motor recovery is completed
within the first month after stroke [37]. Several studies
allocate the greatest recovery from severe aphasia three
months after stroke [38,39]. Spontaneous recovery of
VFD often is only partial and also occurs within the first
weeks up to six months after the damage, however only
in about 38.4% of patients with homonymous hemiano-
pia some spontaneous recovery was observed [40]. It has
to be noted that the term “spontaneous recovery” is
ambiguous because improvements that occur without
intervention are usually non-differentiable from progress
caused be early rehabilitation.
Rønning and Stavem reported that about 7-10% of
their study participants had VFD post stroke [17]. The
ratio of persisting VFD in their sample can only be esti-
mated on the basis of published spontaneous recovery
rates. There is a probability of partial spontaneous VFD
recovery of 50% at one month post injury [40]. This
improvement probability decreases to about 20% at six
months post lesion [40]. Consequently, less than a decile
of the general stroke population had (non-recovered)
VFD six months post lesion.
An inclusion criterion of the VFD-sample was persist-
ing visual field impairment and lesion ages beyond six
months. The mean lesion age was 2.5 years, i.e. four
times higher than the lesion age of the general stroke
sample (6 months). Despite higher lesion age VFD-
patients suffered from lower HRQoL than the general
stroke sample 6 months post lesion. This demonstrates
the significant contribution of VFD on reduced HRQoL
that goes beyond the general stroke-related subjective
impairments in HRQoL.
Another reason for this result may be that within the
first weeks and even months after stroke patients
become aware of constraints due to stroke, e.g. func-
tional impairments, disabilities in working or everyday
activities etc. A psychological hypothesis of post-stroke
depression suggests that social and psychological stres-
sors associated with stroke are the primary causes of
depression [41]. Stroke patients can habituate to these
stressors and develop compensatory strategies in the
next few months implying that there is an additional
component of self-perceived HRQoL increase during the
period of spontaneous recovery and therapy-induced
rehabilitation.
The factor etiology (ischemic vs. hemorrhagic infarc-
tion) does not seem to be related to self-reported visual
impairment (Table 2) since no influence of etiology on
VRQoL and HRQoL was observed in this and in a pre-
vious study [3].
The influence of visual field loss and visual acuity on
quality of life estimates
VRQoL
The results of the present study stress the impact of
intact visual field extensions on QoL estimates. Patients
with a larger intact central visual field showed higher
scores on NEI-VFQ subscales which implies better sub-
jectively perceived VRQoL (Figure 5). Further, the
eccentricity of the VFD was reflected in subjective
VRQoL. Better peripheral vision NEI-VFQ scores were
observed in case of rather intact visual field in the per-
iphery. This also demonstrated the content validity of
the NEI-VFQ questionnaire. However, the correlation
was only weak. This may be due to the fact, that the
analysis was based on campimetry results that tested
only positions within 30° of visual field. Higher correla-
tions are likely to be observed when digital fullfield peri-
metry are obtained which were not available in the
present study.
The present results are in accordance with previous
studies [1,3] that reported an association of larger VFDs
with worse self-evaluated visual functioning. Moreover,
Papageorgiou also observed increasing VRQoL with
advancing size of the area of sparing within the affected
hemifield [1].
Our study also revealed that VRQoL was associated
with visual acuity. Patients with better visual acuity also
showed better VRQoL estimates as revealed by analyses
of variance (Figure 7) and correlation analyses (Table 2).
This relation between VRQoL as measured with the
NEI-VFQ and visual acuity is in agreement with our
previous study [3] where it was shown that visual acuity
was related to VRQoL in all NEI-VFQ scales except
general health, ocular pain and peripheral vision, but
not to HRQoL (SF-36) when age was considered as a
confounding variable.
HRQoL
While there was a distinct influence of visual field
extensions on VRQoL, this was not the case for general
HRQoL (Figure 6). Mental scores of HRQoL were parti-
cularly correlated with the type of the VFD (Table 2). A
small, confined scotoma may have less negative impact
on both overall visual function and cause less psycholo-
gical distress than a quadrantanopia, hemianopia or dif-
fuse loss since the type defines the size of the VFD as
well. Patients with tunnel vision who typically suffer
from the most extensive loss of visual field showed the
worst scores for mental health subscales. However, this
finding is based on only five subjects with tunnel vision.
Similar results suggesting correlations between the size
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patients with postchiasmatic lesions [3] or glaucoma-
patients [5]. Larger VFD cause larger restrictions in
daily life and, besides subjective inconvenience, they
could explain the decline on “mental” SF-36 subscales
such as social functioning, emotional well-being and
role limitations due to emotional problems (Table 2).
Concerning visual acuity, better ratings of emotional
well-being were observed in patients with better visual
acuity. Since emotional well-being also belongs to the
mental component of the SF-36 this is additional evi-
dence that both the size of the VFD as well as visual
acuity predominantly influence mental rather than phy-
sical aspects of quality of life in general.
Limitations of the study
T h er e s u l t so ft h ep r e s e n ts t u d yh a v et ob ei n t e r p r e t e d
with some caution because co-morbidity as a possible
confounding factor for QoL decline was not sufficiently
controlled. As recently shown, co-morbidity in elderly
visually impaired patients is associated with significant
QoL decline [42]. In a large population-based epidemio-
logical study different chronic conditions that often
occur in parallel in the elderly were rank ordered across
dimensions of HRQoL [43]. In this study visual impair-
ments resulting from non-neurologic conditions were
among diseases resulting in less adverse sequelae com-
pared to cerebrovascular and neurologic conditions [43].
A further limitation of the present study is that the
healthy reference samples [29,30] were not identical and
this may be a source of variance. In future studies com-
parisons should be made to healthy control subjects
recruited from a single population representative sample
that answered both the NEI-VFQ and the SF-36.
An issue for further research is that the extent of the
visual field defect as investigated in the presented study
does not constitute the only factor influencing VRQoL.
The eccentricity of the visual field loss may also play a
major role since more central or even foveal visual field
defects may result in worse VRQoL than peripheral
defects of the visual field.
Conclusions
VFD-patients after first posterior parietal-stroke showed
severely reduced VRQoL and HRQoL even 2.5 years after
the lesion. Compared with the investigated stroke
patients with VFD the impairment level of stroke patients
in general was larger concerning HRQoL 1 month post
lesion but smaller at 6 months post lesion. This indicates
that the stroke-related impairment level is significantly
exacerbated by VFD. Since VFD occur in approximately
10% of stroke patients, patients with persisting VFD
should be offered additional neuropsychological rehabili-
tation that may improve visual functioning [31] or
supportive psychotherapeutic interventions because of
their significantly reduced subjective mental health.
Additional file 1: Overview of studies examining the relation
between QoL measures and visual field loss after different
etiologies. The table presents study results for (I) visual field loss in
glaucoma, (II) visual field loss after retinal lesions, (III) visual field loss after
pre- and postchiasmatic lesions, and finally (IV) results of a population-
based cross-sectional study. Information on the studied samples, and the
way how visual fields and QoL were assessed are given. Note that
statistical analyses and study results do not represent the whole content
of the cited studies and are restricted on research questions targeting
the relation between QoL and visual field loss.
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